多发性硬化(MS)的发病机制尚未完全阐明,故尚无特效疗法。近来对MS免疫学障碍的研究成果推动了治疗的发展。本文简述了免疫治疗的理论依据,对常用的药物如皮质类固醇激素,环磷酰胺、硫唑嘌呤作了初步评价,另外介绍了干扰素、单克隆抗体等药物以及放疗和血浆交换疗法的国外研究动态。 The pathogenesis of multiple sclerosis (MS) has not been fully elucidated, so there is no effective therapy. Recent research on the immunological disorders of MS has led to the development of therapies. This article describes the theoretical basis of immunotherapy, the commonly used drugs such as corticosteroids, cyclophosphamide, azathioprine made a preliminary assessment, in addition to the introduction of interferon, monoclonal antibodies and other drugs and radiotherapy and plasma exchange therapy abroad Research trends